Christopher P. Cannon

2 ta ish

Royal North Shore Hospital

1. The Evolving Future of PCSK9 Inhibitors

   Robert S. Rosenson, Robert A. Hegele, Sergio Fazio +1

   Sharh maqolaOAOchiq kirish20184 iqtibos

   ABIABI:AkademIndex/2026.other.244584

2. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

   Vlado Perkovic, Meg Jardine, Bruce Neal +21

   Maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.720708